Vimarsana
Biggest News Aggregation in the World

Page 6 - Linical Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Evolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Evolution Today - Breaking & Trending Today

Stevanato bringing advanced biopharmaceutical products to market - Vimarsana News

Stevanato bringing advanced biopharmaceutical products to market

Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.

Stevanto bringing advanced biopharmaceutical products to market - Vimarsana News

Stevanto bringing advanced biopharmaceutical products to market

Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.

IQVIA: As use of AI, ML and NLP increases - compliance must keep up - Vimarsana News

IQVIA: As use of AI, ML and NLP increases - compliance must keep up

Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more frequently. Naturally with more and more people using it for work, new regulations on data use and management are starting to appear.

Colleen Acosta - addressing the unmet needs in women's health - Vimarsana News

Colleen Acosta - addressing the unmet needs in women's health

Colleen Acosta is CEO of Freya Biosciences which is a trans-Atlantic clinical-stage biotech company pioneering microbial immunotherapies aimed at relieving the chronic inflammation underlying a range of women’s reproductive system conditions and we were excited to put our Women in Science questions to her.

SCOPE 2024 - driving innovation in clinical trials - Vimarsana News

SCOPE 2024 - driving innovation in clinical trials

OM1 says it wants to stand at the helm of a healthcare revolution, fostering an integrated approach to generating and utilizing real-world evidence (RWE), reshaping the foundation of healthcare.